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AbsTrACT
background Physical activity recommendations state 
that for the same energy expenditure, moderate-to-
vigorous physical activities (MVPAs) produce similar health 
benefits. However, few epidemiological studies have tested 
this hypothesis.
Design We examined whether, compared with moderate, 
vigorous activity was associated with larger mortality risk 
reductions.
Methods Data from 11 cohorts of the Health Survey for 
England and the Scottish Health Survey, collected from 
1994 to 2011 (mean (SD) follow-up, 9.0 (3.6) years). Adults 
aged ≥30 years reported MVPA and linkage to mortality 
records. Exposure was the proportion of self-reported 
weighted MVPA through vigorous activity. Outcomes 
were all-cause, cardiovascular disease (CVD) and cancer 
mortality.
results Among 64 913 adult respondents (44% men, 
56% women, mean (SD) age, 49.8 (13.6) years), there 
were 5064 deaths from all-causes, 1393 from CVD 
and 1602 from cancer during 435 743 person-years of 
follow-up. Compared with those who reported no vigorous 
physical activity, and holding constant the volume of 
weighted MVPA, vigorous activity was associated with 
additional reductions in mortality risk. For all-cause 
mortality, the adjusted HR was HR=0.84 (95% CI 0.71, 
0.99) and HR=0.84 (95% CI 0.76, 0.94) among those who 
reported between >0% and<30%, or ≥30% of their activity 
as vigorous, respectively. For CVD and cancer mortality, 
point estimates showed similar beneficial associations yet 
CIs were wider and crossed unity.
Conclusion Vigorous activities were associated with 
larger reductions in mortality risk than activities of 
moderate intensity, but no evidence of dose–response 
effects was found.
bACkgrounD
The health benefits of physical activity are 
well established.1 Physical inactivity is the 
fourth leading risk factor for global mortality,2 
causing an estimated 5.3 million deaths 
per year.3 Guidelines from the USA,4 UK,5 
Australia6 and the WHO7 recommend that to 
achieve significant health benefits, including a 
lower mortality risk, adults should accumulate 
at least 150 min of moderate activity (3–5.9 
metabolic equivalent tasks, METs), or 75 min 
of vigorous activity (≥6 METs) per week, or a 
combination of both where 1 min of vigorous 
activity counts approximately the same as 
2 min of moderate intensity activity. This 
implies that when the overall activity energy 
expenditure is held constant, moderate and 
vigorous intensity activities produce similar 
health benefits. However, activities of at least 
vigorous intensities are required to improve 
or maintain cardiorespiratory fitness in 
healthy populations,8–13 which is considered a 
powerful predictor of clinical outcomes14 and 
mortality.15–19
To date, few epidemiological studies have 
examined the association between the inten-
sity of physical activity and mortality while 
controlling for the volume of activity, yielding 
mixed results.20–24 While some prospective 
studies found a lower risk in all-cause20 23 24 
and cardiovascular disease (CVD) mortality21 
in participants reporting larger proportions 
of vigorous intensity, another study found 
inconsistent associations with CVD mortality 
What is already known?
 ► A higher volume of physical activity is associated 
with lower mortality risk, but it is unknown whether 
vigorous activity may yield larger reductions on mor-
tality risk than energy-matched activities of lower 
intensity.
What is the new finding?
 ► In this cohort, vigorous physical activity was asso-
ciated with larger reductions on all-cause mortality 
risk than activities of lower intensity.
 ► No evidence of dose-response effects on reductions 
of mortality was found with vigorous activities. For 
cancer mortality risk, no conclusive evidence was 
found about the role of vigorous activities.
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in both sexes and a reduction in all-cause mortality only 
in men.22 Regarding the influence of physical activity on 
cancer, a recent meta-analysis25 observed an inverse asso-
ciation between the volume of physical activity and the 
risk of cancer mortality.
To our knowledge, no previous epidemiological studies 
have examined the role of vigorous activity (vs moderate 
and holding constant total physical activity) in cancer 
mortality.
Using data from a series of large British cohorts, we 
examined whether the proportion of total physical 
activity accrued by vigorous activities was associated with 
all-cause, CVD and total cancer mortality independent of 
the total amount of activity.
MeThoDs
Population
The Health Survey for England (HSE) and the Scottish 
Health Survey (SHeS) are household-based prospec-
tive studies in which households were selected using 
a multistage, stratified probability design to achieve 
representative samples of the population of England 
and Scotland. Stratification was based on geographical 
characteristics (postcode sectors were selected at the 
first stage). Local research ethics committees approved 
the data collection of each survey. The present study 
included 11 population cohorts of individuals aged 30 
years or older: HSE 1994, 1997, 1998, 1999, 2003, 2004, 
2006 and 2008; SHeS 1995, 1998 and 2003.26 27 For this 
study, we excluded all individuals that reported no moder-
ate-to-vigorous physical activity (MVPA) and/or did not 
provide information for any of the covariates included in 
the statistical models.
Measurement of exposure
Physical activity was measured by an interviewer-ad-
ministered questionnaire as described elsewhere.28 29 
Participants were asked about the frequency, dura-
tion and pace of walking (slow, average or brisk) and 
domestic physical activity. In addition, data on physical 
activity in sports and exercise were collected (frequency, 
duration and perceived intensity over the last 4 weeks) 
using a prompt card. This contained 10 main group-
ings, including cycling, swimming, running, football, 
rugby, tennis and squash. Up to six open entries could 
be recorded. Perceived moderate intensity activities 
correspond to a slight increase in the heart rate (3.0–5.9 
METs), whereas vigorous activities get people out of 
breath and make them sweat (6.0 or more METs, where 
1 MET represents the resting energy expenditure).4 The 
criterion validity of the physical activity questionnaire 
used in the HSE has been described previously.29
Measurement of the outcomes
The British National Health Service Central Registry 
flagged all participants. Primary cause of death was 
determined based on the codes from the International 
Classification of Diseases, Ninth Revision (ICD-9) and 
the International Statistical Classification of Diseases and 
Related Health Problems, Tenth Revision (ICD-10). CVD 
mortality codes were 390 to 459 for ICD-9 and I01 to I99 
for ICD-10, and for cancer mortality were 140 to 239 for 
ICD-9 and C00 to D48 for ICD-10.
Covariates
Height and weight were measured objectively by trained 
interviewers following standard protocols.26 27 Body 
mass index (BMI) was calculated as weight in kilo-
grams divided by height in metres squared. Then, we 
categorised participants as normal weight (BMI <25) 
and overweight/obese (BMI ≥25). Education level was 
assessed as the age at which each participant finished 
full-time education (recoded into ≤15, 15–18 and ≥19 
years old). For alcohol consumption, researchers asked 
the frequency of drinking during the last week (recoded 
into <5 or ≥5 times/week). Smoking status was catego-
rised as never or ex-regular or ex-occasional or current 
smoker. Longstanding illness was defined when indi-
viduals had at least one illness within a list of illnesses 
affecting different body systems (ie, the nervous system, 
heart and circulatory system). Cancer or CVD (angina, 
stroke and coronary heart disease) diagnosis was based 
on medical reports. The General Health Questionnaire 
(GHQ-12) was used to assess psychological distress which 
is considered a valid tool.30
statistical analysis
Cox proportional hazards regression models were used 
to estimate the association between the proportion of 
total weighted MVPA as vigorous activity and all-cause, 
CVD and cancer mortality. We examined the propor-
tional hazards assumption and, as statistical tests were 
violated (χ2=28.43, p=0.0002), we alternatively used strat-
ified Cox proportional regression models. By doing so, 
no violations were noted (χ2=4.35, p=0.23). Cox models 
were stratified by age, sex, education and smoking and 
adjusted for alcohol consumption, total weighted volume 
of MVPA and longstanding illness. For the outcome CVD 
mortality, models were additionally adjusted for CVD 
diagnosis at baseline. For cancer mortality, models were 
additionally adjusted for cancer diagnosis at baseline. To 
account for potential reverse causation through occult 
disease at baseline, analyses were repeated excluding 
those subjects who died during the first 24 months 
of follow-up. We created the variable ‘proportion of 
weighted MVPA by vigorous activity’ (three levels) based 
on the cut-points used in two previous publications23 24: 
(1) 0%; (2)>0% to <30%; and (3) ≥30% of MVPA by 
vigorous activity.
Sensitivity analyses were also performed to account 
for additional confounders. Model 1 was addition-
ally adjusted for BMI. Model 2 included model 1 plus 
psychological distress. Because of the relatively small 
size of the >0% to <30% of MVPA by vigorous physical 
activity group, we also regrouped the exposure variable 
using a distribution-driven approach to elicit more equal 
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groups: 0% of vigorous; > 0 to <60% of physical activity as 
vigorous: >60% of MVPA as vigorous (online supplemen-
tary table 2). Finally, we explored associations comparing 
the highest intensity level achieved by participants versus 
moderate intensity (online supplementary table 3). All 
analyses were performed with the statistical package 
STATA V.14 (StataCorp, College Station, Texas, USA).
resulTs
Descriptive characteristics of the sample are shown 
in table 1. Of the 64 913 adult respondents, 56% were 
women, 59.5% were overweight or obese, 75.8% were 
non-current smokers, 80% did not drink alcohol 
frequently (less than five times per week) and 84.7% did 
not report psychological distress. More than half (58.3%) 
of the participants met the WHO’s physical activity 
recommendations7 of 150 min of weighted MVPA per 
week. Of those who engaged in any MVPA, 68.6% did not 
report any vigorous activity, 7.7% reported less than 30% 
and 23.7% reported 30% or more of their total MVPA 
as vigorous activity. The highest total volume of physical 
activity was in the 0%–30% vigorous group, who reported 
a median of 461 min per week of MVPA. Participants who 
were younger, male and sufficiently active were more 
likely to engage in some vigorous activity. The main anal-
yses included 64 913 (all-cause mortality), 57 702 (CVD 
mortality) and 63 677 (cancer mortality) participants.
All-cause mortality
Table 2 presents the associations between the proportion of 
MVPA weighted by vigorous activity and all-cause mortality. 
Of the 64 913 participants, 5064 deaths were registered 
during 435 743 person-years of follow-up (mean (SD) 
follow-up, 9.0 (93.6) years). In the whole sample, compared 
with those not engaging in any vigorous activity (0%), the 
adjusted HR for all-cause mortality was as follows: HR=0.84 
(95% CI 0.71, 0.99) for participants reporting between 
>0 and <30% of MVPA as vigorous; and HR=0.84 (95% CI 
0.76, 0.94) for those reporting ≥30% of MVPA as vigorous. 
In men, the adjusted HR=0.88 (95% CI 0.71, 1.10) in the 
group >0 to<30%, and HR=0.81 (95% CI 0.70, 0.93) in 
the group ≥30% of MVPA as vigorous activity. In women, 
HR=0.77 (95% CI 0.58, 1.01) and HR=0.90 (95% CI 0.77, 
1.05), respectively. The beneficial associations observed 
with vigorous activity were attenuated with age. For 
example, for those who reported 30% or more of MVPA as 
vigorous activity, the adjusted HR for all-cause mortality was 
0.73 (95% CI 0.59, 0.91) in participants aged 30–49 years 
old versus HR=0.93 (95% CI 0.79 to 1.10) in participants 
aged ≥65 years. Regardless of whether individuals met 
physical activity guidelines or not, vigorous physical activity 
showed protective effects on all-cause mortality risk. For 
example, we found a 15% risk reduction (HR=0.85, 95% CI 
0.74, 0.98) in participants who achieved the recommended 
150 min of MVPA and reported 30% or more of vigorous 
activity; and a 12% non-statistically significant reduction 
(HR=0.88, 95% CI 0.74, 1.05) in those that did not meet 
the physical activity guidelines.
CVD mortality
Table 3 shows point estimates and CIs between the propor-
tion of MVPA as vigorous activity and CVD-mortality risk. In 
the whole sample, the adjusted HRs were HR=0.83 (95% 
CI 0.57 to 1.18) and HR=0.84 (95% CI 0.68 1.04) for partic-
ipants reporting >0% to <30% and ≥30%, respectively. 
However, estimates were imprecise as indicated by their 
wide CIs (eg, in women HR=0.61 (95% CI 0.30, 1.25) in the 
category group >0% to <30% of MVPA by vigorous activity). 
In analyses stratified by age, there was weak evidence for 
associations, despite in the youngest group with ≥30% of 
MVPA as vigorous, the risk of CVD was 41% lower (95% CI 
0.36 to 0.97). Stratifying participants by adherence to the 
physical activity recommendations showed no evidence 
of association in most subgroups, with the only exception 
of meeting activity guidelines and ≥30% of their MVPA as 
vigorous (HR=0.71, 95% CI 0.53, 0.97).
Cancer mortality
Table 4 shows results of the analyses with cancer mortality 
as the outcome. In the whole sample, there was weak 
evidence of vigorous activity being associated with lower 
cancer mortality risk: HR=0.79 (95% CI 0.60, 1.06) and 
HR=0.89 (95% CI 0.75, 1.06) for participants reporting 
>0% to <30% and ≥30% of MVPA as vigorous, respectively. 
However, in most subgroup analyses estimates were less 
consistent and pointed towards no association. In analyses 
stratified by sex, there was evidence of a beneficial associa-
tion of a high proportion of vigorous activity with cancer 
mortality risk HR=0.83 (95% CI 0.65, 1.05) only in men. In 
analyses stratified by age, we found evidence of an associ-
ation with cancer mortality only among participants aged 
50–65 years: HR=0.66 (95% CI 0.43, 1.04) and HR=0.77 
(95% CI 0.60, 1.00) for >0% to <30% and ≥30%, respec-
tively.
sensitivity analyses
Online supplementary table 1 includes the same statis-
tical models of survival analyses previously used but 
adjusted for other covariates. Model 1 was additionally 
adjusted for BMI. Model 2 included model 1 plus psycho-
logical distress. Results did not change the pattern of the 
findings shown in tables 2–4.
When using an alternative categorisation of the propor-
tion of MVPA as vigorous (0%,>0 to <60%, ≥60%) (online 
supplementary table 2), which was more balanced in 
terms of group sample size, we found that only low to 
moderate proportions of vigorous activity (>0 to <60%) 
were associated with lower mortality risk (for all causes, 
CVD and cancer). Similarly, when we explored another 
simple indicator of intensity (highest PA intensity 
achieved), vigorous intensity was again associated with 
lower mortality risk (online supplementary table 3).
DisCussion
Principal findings
Using pooled data from 11 cohorts from England and 
Scotland, we examined the association between different 
relative proportions of vigorous physical activity and 
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Table 1 Characteristics of participants at baseline (n=64 913) in the Health Survey for England and Scottish Health Survey
Number (%) of participants
Variable
Proportion of moderate to vigorous activity classified as 
vigorous Total participants, 
n0% >0% to <30% ≥30%
Total sample, n (%) 44 521 (68.6) 5000 (7.7) 15 392 (23.7) 64 913
Sex, n (%)
  Male 18 421 (64.5) 2341 (8.2) 7805 (27.3) 28 567
  Female 26 100 (71.8) 2659 (7.3) 7587 (20.9) 36 346
Age group, y
  30–49 20 363 (58.3) 3521 (10.1) 11 024 (31.6) 34 908
  50–64 14 441 (75.8) 1202 (6.3) 3413 (17.9) 19 056
  65-max 9717 (88.7) 277 (2.5) 955 (8.7) 10 949
Age finished full-time education,
n (%)
  ≤15 y 18 216 (82.8) 1042 (4.7) 2745 (12.5) 22 003
  16–18 y 19 329 (64.8) 2617 (8.8) 7876 (26.4) 29 822
  ≥19 y 6976 (53.3) 1341 (10.2) 4771 (36.5) 13 088
  Smoking status, n (%)
  Non-current 32 508 (66.1) 3930 (8.0) 12 736 (25.9) 49 174
  Current 12 013 (76.3) 1070 (6.8) 2656 (16.9) 15 739
Alcohol consumption frequency,
n (%)
  <5 times/week 35 979 (68.8) 3953 (7.6) 12 317 (23.6) 52 249
  ≥5 times/week 8542 (67.4) 1047 (8.3) 3075 (24.3) 12 664
Long-standing illness, n (%)
  No 24 071 (64.8) 3178 (8.5) 9906 (26.7) 37 155
  Yes 20 450 (73.7) 1822 (6.5) 5486 (19.8) 27 758
Weighted MVPA, min/week
  10–149 23 126 (85.7) 485 (1.8) 3380 (12.5) 26 991
  ≥150 21 362 (56.5) 4496 (11.9) 11 960 (31.6) 37 818
  Median physical activity levels 
(IQRs)
195 (80–442.5) 137.5 (60–322.5) 461.4 (255–817) 329 (165–615)
BMI, n (%)
  <25 (normal weight) 17 941 (67.1) 2189 (8.2) 6603 (24.7) 26 733
  ≥25 (overweight/obesity) 26 902 (69.6) 2843 (7.4) 8880 (23.0) 38 625
  BMI, mean (SD) 24.86 (9.18) 24.53 (8.34) 24.60 (8.64) 24.78 (8.99)
Psychological distress, n (%)
  No: GHQ score <4 37 450 (68.1) 4273 (7.8) 13 253 (24.1) 54 976
  Yes: GHQ score ≥4 5718 (70.4) 623 (7.7) 1781 (21.9) 8122
Smoking status was based on one question with the following options: never, ex-regular smoker, ex-occasional smoker, current smoker. 
Alcohol use was derived from the question “On how many days in the last 7 days did you have an alcoholic drink?”. Long standing illness 
included at least one illness from a list of body systems (ie, nervous system, heart and circulatory system). The definition of psychological 
distress was based on the General Health Questionnaire (GQH) comprising 12 questions related with psychological health.
BMI, body mass index; MVPA, moderate-to-vigorous physical activity; max, maximal; y, years.
all-cause, CVD and cancer mortality risk. Our overall 
findings support the hypothesis that activities of vigorous 
activity may provide additional reductions in mortality 
risk (ie, 16% risk reduction for all-cause mortality), in line 
with results obtained elsewhere,23 24 yet for cause-specific 
mortality (CVD, cancer) uncertainty arose as point esti-
mates were wider and crossed the unity.
In contrast to a previous study,23 we did not find 
evidence of a dose–response reduction in mortality risk 
with a larger proportion of vigorous activity, which is in 
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Table 2 Stratified Cox regression (by age, sex, education and smoking) describing associations between vigorous activity 
and all-cause mortality
Proportion of moderate to vigorous activity classified as vigorous
Variable
Total No. of 
Participants/Events
0% >0% to <30% ≥30%
N/Events Reference N/Events HR (95% CI) N/Events HR (95% CI)
All sample 64 913/5064 44 521/4477 1 5000/151 0.84 (0.71 to 0.99) 
p=0.04
15 392/436 0.84 (0.76 to 
0.94) p=0.002
All sample 
(excluding first 24 
months of death)
64 186/4507 43 924/3986 1 4972/135 0.84 (0.70 to 1.01) 
p=0.05
15 290/386 0.85 (0.76 to 
0.95) p=0.005
Sex
  Men 28 567/2630 18 421/2296 1 2341/94 0.88 (0.71 to 1.10) 
p=0.28
7805/240 0.81 (0.70 to 
0.93) p=0.003
  Women 36 346/2434 26 100/2181 1 2659/57 0.77 (0.58 to 1.01) 
p=0.06
7587/196 0.90 (0.77 to 
1.05) p=0.19
Age group, y
  30–49 34 908/606 20 363/431 1 3521/58 0.95 (0.71 to 1.27) 
p=0.74
11 024/117 0.73 (0.59 to 
0.91) p=0.006
  50–64 19 056/1388 14 441/1181 1 1202/51 0.74 (0.55 to 0.98) 
p=0.04
3413/156 0.84 (0.71 to 
1.01) p=0.05
  ≥65 10 949/3070 9717/2865 1 277/42 0.81 (0.59 to 1.11) 
p=0.20
955/163 0.93 (0.79 to 
1.10) p=0.38
Weighted MVPA, 
min/week
  10–149 26 991/2888 23 126/2719 1 485/18 0.91 (0.56 to 1.48) 
p=0.71
3380/151 0.88 (0.74 to 
1.05) p=0.147
  >150 37 895/2149 21 395/1758 1 4515/133 0.87 (0.72 to 1.04) 
p=0.132
11 985/258 0.85 (0.74 to 
0.98) p=0.02
For all sample values were adjusted for alcohol consumption, total weighted volume of moderate-to-vigorous physical activity (MVPA) 
and longstanding illness.
N, total population; No, number.
line with other studies.22 24 It must be noted, however, that 
the benefits of vigorous activity in all-cause mortality risk 
were restricted to young and middle-aged participants, 
unlike a previous study where the benefits were indepen-
dent of the age of participants.23 The null association 
observed in older adults in the present study could be 
due to their low physical activity levels. For example, in 
the study of Gebel et al,23 61% of participants aged 65–75 
years reported no vigorous activity vs 89% in the current 
study (see table 1).
For CVD mortality (table 2), we found weak evidence 
linking vigorous activity with additional reductions in 
mortality risk. The protective CVD effect of vigorous 
intensity was only observed in men in agreement with 
data found in Shiroma et al.22 We noted that the bene-
fits were mainly accrued to ‘any vigorous activity’ (the 
0%–30% vigorous activity group). The categorisation 
of the exposure variable was directly comparable to 
studies published in Australia23 and Japan,24 but this 
posed some analytical challenges as there was a rela-
tively small number of participants in the middle group 
category (>0% to <30% of MVPA by vigorous activity). 
In sensitivity analysis where an alternative categori-
sation of the VPA exposure variable was used to elicit 
exactly balanced sample sizes between groups (online 
supplementary table 2), we found evidence of benefi-
cial associations for the middle category (>0 to <60% 
of MVPA by vigorous activity) on all-cause and cancer 
mortality, but with the highest doses of vigorous activity 
(≥60% of MVPA), the protective associations found 
with all outcomes were not statistically significant. The 
hypothesis that an excessive amount of exercise at high 
intensity could adversely affect cardiac function and 
increase CVD mortality risk is a topic of debate,31 but 
this hypothesis is not supported by the results of our 
observational study.
Regarding cancer mortality, we found inconsistent 
results (evidence of a protective association with the 
whole sample, but weak evidence across subgroup 
analyses). These uncertainties seem concordant with 
the limited evidence of the preventive role of physical 
activity on many cancer sites.32 Another limitation in our 
analysis is that all cancer deaths were pooled into one 
outcome variable. Future studies about this topic should 
explore associations between intensities of physical 
activity and incidence and mortality of cancer-specific 
sites.
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Table 3 Stratified Cox regression (by age, sex, education and smoking) describing associations between vigorous activity 
and cardiovascular (CVD) mortality
Proportion of moderate to vigorous activity classified as vigorous
Variable
Total No. of 
Participants/Events
0% >0% to <30% ≥30%
N/Events Reference N/Events HR (95% CI) N/Events HR (95% CI)
All sample 57 702/1393 39 913/1252 1 4316/35 0.83 (0.57 to 1.18) 
p=0.31
13 473/106 0.84 (0.68 to 1.04) 
p=0.11
All sample 
(excluding first 24 
months of death)
57 119/1270 39408/1142 1 4296/32 0.83 (0.57 to 1.20) 
p=0.32
13 415/96 0.84 (0.67 to 1.05) 
p=0.126
Sex
  Men 25 381/766 16 528/676 1 2023/27 0.94 (0.63 to 1.41) 
p=0.76
6830/63 0.78 (0.60 to 1.03) 
p=0.08
  Women 32 321/627 23 385/576 1 2293/8 0.61 (0.30 to 1.25) 
p=0.18
6643/43 0.94 (0.68 to 1.31) 
p=0.72
Age group, y
  30–49 30 760/124 18 126/92 1 047/10 0.71 (0.36 to 1.39) 
p=0.31
9587/22 0.59 (0.36 to 0.97) 
p=0.04
  50–64 17 209/311 13 141/263 1 1037/9 0.63 (0.32 to 1.23) 
p=0.17
3031/39 0.96 (0.68 to 1.36) 
p=0.84
  ≥65 9733/958 8646/897 1 232/16 0.79 (0.48 to 1.30) 
p=0.35
855/45 0.65 (0.48 to 0.88) 
p=0.005
Weighted MVPA, 
min/week
  10–149 24 500/850 20 999/795 1 439/4 0.82 (0.29 to 2.27) 
p=0.70
3062/51 1.05 (0.77 to 1.43) 
p=0.75
  >150 33 202/543 18 914/457 1 3877/31 0.84 (0.57 to 1.25) 
p=0.39
10 411/55 0.71 (0.53 to 0.97) 
p=0.03
For all sample values were adjusted for alcohol consumption, total weighted volume of moderate-to-vigorous physical activity (MVPA), 
longstanding illness and CVD diagnosis at baseline.
N, total population; No, number.
strengths and limitations of the study
Our study included cause-specific death records from a 
series of large, nationally representative cohorts. In large 
cohort studies,23 physical activity data are commonly 
collected by questionnaires which may lead to recall 
biases.33 34 However, vigorous activity is considered a 
more accurate reported variable compared with activi-
ties of lower intensity.34–36 To minimise the risk that our 
findings could be explained by reverse causation, the 
reference category in our analyses included those with 
some moderate physical activity (but no vigorous activity) 
based on a previous study.23 A recent study from Japan24 
included the two different comparator groups (phys-
ically inactive and moderate intensity active groups), 
and larger effect sizes were observed using the inactive 
group as reference. Nonetheless, given the limitations 
inherent in any observational study, we cannot totally 
discard that our associations may have been biased. A 
lack of adjustment for unknown confounders (ie, dietary 
factors, undetected comorbidities) may challenge the 
internal validity of our findings. We also excluded all 
deaths during the first 2 years of follow-up and the results 
remained broadly the same. However, future epidemi-
ological studies should employ more strict criteria to 
control for reverse causation (ie, excluding participants 
after the first 4 or 6 years of follow-up).
Public health implications
Although the first public health goal is to meet physical 
activity guidelines (regardless of the intensity achieved), 
our data indicate that a single estimate of vigorous activity 
in adulthood is associated with lower mortality risk 
compared with activities of moderate intensity. Finally, 
our stratified analysis also supports the importance of 
accumulating a minimal amount of activity for health 
purposes because in participants who achieved less than 
150 weekly minutes of MVPA, vigorous activity was not 
associated with lower mortality.
We conclude that holding constant the amount of phys-
ical activity, vigorous activity may confer larger reductions 
in mortality risk than activities of moderate intensity.
Patient and public involvement
Patients were not involved in the design, recruitment, or 
execution of this study.
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Table 4 Stratified Cox regression (by age, sex, education and smoking) describing associations between vigorous activity 
and cancer mortality
Proportion of moderate to vigorous activity classified as vigorous
Variable
Total No. of 
Participants/Events
0% >0% to<30% ≥30%
N/Events Reference N/Events HR (95% CI) N/Events HR (95% CI)
All sample 63 677/1602 43 576/1384 1 4936/53 0.79 (0.60 to 1.06) 
p=0.12
15 165/165 0.89 (0.75 to 1.06) 
p=0.20
All sample 
(excluding first 24 
months of death)
63 018/1447 43 039/1247 1 4912/51 0.83 (0.62 to 1.11) 
p=0.21
15 067/149 0.89 (0.74 to 1.06) 
p=0.20
Sex
  Men 2 8111/805 18 068/692 1 2315/29 0.83 (0.56 to 1.22) 
p=0.34
7728/84 0.83 (0.65 to 1.05) 
p=0.13
  Women 35 566/797 25 508/692 1 2621/24 0.78 (0.51 to 1.19) 
p=0.25
7437/81 0.98 (0.77 to 1.25) 
p=0.86
Age group, y
  30–49 34 593/218 20 166/154 1 3491/21 0.96 (0.60 to 1.55) 
p=0.87
10 936/43 0.78 (0.54 to 1.11) 
p=0.17
  50–64 18 593/612 14 093/523 1 1180/21 0.66 (0.43 to 1.04) 
p=0.07
3320/68 0.77 (0.60 to 1.00) 
p=0.05
  ≥65 10 491/772 9317/707 1 265/11 0.65 (0.36 to 1.19) 
p=0.16
909/54 0.97 (0.74 to 1.29) 
p=0.86
Weighted MVPA, 
min/week
  10–149 26 991/2888 23 126/2719 1 485/18 0.67 (0.27 to 1.67) 
p=0.39
3380/151 0.90 (0.66 to 1.21) 
p=0.47
  >150 37 895/2149 21 95/1758 1 4515/133 0.85 (0.62 to 1.15) 
p=0.30
11 985/258 0.93 (0.75 to 1.16) 
p=0.54
For all sample values adjusted for alcohol consumption, total weighted volume of moderate-to-vigorous physical activity (MVPA), 
longstanding illness and baseline cancer diagnosis at baseline.
N, total population; No, number.
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